Muscle relaxant study in asian volunteers – no cure, just data

NCT ID NCT07464535

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early-stage study gave 20 healthy Japanese and Chinese adults a single dose of TNX-102 SL (a cyclobenzaprine tablet placed under the tongue) to see how the drug moves through their bodies. Researchers compared two doses and checked safety. The goal was only to gather information, not to treat any disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

TNX-102 SL (cyclobenzaprine sublingual tablet)

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS (HS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Altasciences Clinical Los Angeles, Inc.

    Cypress, California, 90630, United States